 |
|
|
Patient Monitoring & Connectivity 
Anesthesia Delivery & Ventilation 
Diagnostic Cardiology 
Clinician Education 
Spacelabs Telemetry Again Ranks #1
Sunday, April 18, 2010
For immediate release
Spacelabs Telemetry Monitors Again Rank #1
Issaquah, Wash., April 15, 2010 – According to MD Buyline’s April 2010 report, telemetry monitors from Spacelabs Healthcare have again earned the highest customer satisfaction rating, compared with scores from users of eight competing telemetry suppliers. In this most recent survey, Spacelabs ranks highest in all categories; System Performance, System Reliability, Installation/Implementation, Applications Training, Service Response Time and Service Repair Quality.
“The most important measure of our success is how well we serve our customers,” said Joe Davin, Group President at Spacelabs Healthcare. “Consistently achieving this top ranking clearly indicates that our continued emphasis on quality has earned the recognition of our customers.”
Spacelabs Healthcare pioneered telemetry in 1958 when tasked with monitoring the vital signs of NASA’s Gemini astronauts, and then was first to introduce telemetry to hospitals. Today, hospitals around the world depend on Spacelabs Healthcare’s telemetry for continuous, reliable monitoring of ambulatory patients.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the evaluation of the Company’s telemetry devices. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.